Replies to post #91947 on Cytodyn Inc (CYDY)

[bwolfy2002]

I believe this is accurate. It’s a complicated landscape but I don’t think as of today they qualify for any uplist. They need either more time at these prices, shareholder equity, or both to begin the process.

Shareholder equity probably is not coming anytime before an FDA approval to sell Leronlimab. That would presumably turn inventory into an asset as something you can’t sell shouldn’t be an asset.

This is a general outline as in I’ve ruffled through all the PDFs for NYSE and whatever AMEX is called now at NYSE and NAZ, but don’t recall every detail. Safe to say it probably won’t occur until an approval.